<!DOCTYPE html>
<html>
	<head>
	 <meta charset="UTF-8">
	 <meta name="description" content="This is an awesome website!">
	<title>Bill's awesome website</title>
	</head>
	<body style="background-color:lightblue;">
<h1 align="center">Bill's Awesome Website</h1>
  <a href="index.html" >Home</a>
	<a href="About.html" >About</a>
	<a href="September.html" >September</a>
	<a href="October.html" >October</a>
	<a href="November.html" >November</a>
	<a href="December.html" >December</a>
  <a href="WatchList.html">WatchList</a>
<hr>




<p>
		<img width="500" src="sept.png" />

    <h1>ETON PHARMACEUTICALS INC</h1>

<!-- TradingView Widget BEGIN -->
<!-- TradingView Widget BEGIN -->
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/NASDAQ-ETON/" rel="noopener" target="_blank"><span class="blue-text">ETON Symbol Info</span></a> by TradingView</div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
  {
  "symbol": "NASDAQ:ETON",
  "width": 1000,
  "locale": "en",
  "colorTheme": "light",
  "isTransparent": false
}
  </script>
</div>
<!-- TradingView Widget END -->

  <p> <b>E</b>ton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen,
  a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
  It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital
  setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300
  and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.
  <i>Source Fidelity.com</i>
  </p>

<dl>
  <dt><b>ETON PDUFA Dates</b></dt>
    <dd>September 15th - <i>Delayed</i></dd>
    <dd>September 29th</dd>



  <h1>Research Links</h1>

<p><a href="https://etonpharma.com/" target="_blank" >Company Website</a></p>
<p><a href="https://finance.yahoo.com/quote/ETON?p=ETON" target="_blank">Yahoo Fiance</a></p>
<p><a href="https://stocktwits.com/symbol/ETON" target="_blank">StockTwits</a></p>
<p><a href="https://www.tradingview.com/symbols/NASDAQ-ETON/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></p>
<p><a href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></p>

<p>

</p>



	</body>
</html>
